BIO-key's CEO will hold virtual meetings at H.C. Wainwright’s conference, with on-demand presentations available for attendees.
Quiver AI Summary
BIO-key International, Inc. announced that its CEO, Michael DePasquale, will hold virtual meetings during H.C. Wainwright's 28th Annual Global Investment Conference on September 15 and 17, 2026. Attendees interested in meeting with him can schedule through H.C. Wainwright representatives or by contacting Lily Khaykina. Additionally, BIO-key's presentation will be available on-demand for registered participants starting September 11. BIO-key specializes in biometric authentication and identity management solutions, offering services designed to enhance cybersecurity for over forty million users through flexible, multi-factor authentication options. The conference will showcase various leading companies in growth sectors, with H.C. Wainwright providing comprehensive investment banking services.
Potential Positives
- BIO-key’s CEO will engage with investors during H.C. Wainwright’s prestigious conference, potentially enhancing investor relations and visibility in the market.
- The conference presentation will be available on demand, maximizing exposure and access to potential investors who may be interested in the company's offerings.
- The company highlights its leadership position in Identity and Access Management and biometric authentication technology, reinforcing its credibility and market relevance.
Potential Negatives
- The press release does not provide any new product updates or significant achievements that would enhance investor confidence or interest in the company.
- There is a lack of mention regarding the company's financial performance or outlook, which could leave investors with uncertainties about its future prospects.
- The reliance on a single conference for investor engagement may indicate limited marketing efforts or opportunities for broader visibility in the market.
FAQ
When will BIO-key's CEO be available for virtual meetings?
BIO-key's CEO Michael DePasquale will be available for virtual meetings on September 15th and 17th, 2026.
How can I schedule a meeting with BIO-key's CEO?
To schedule a meeting, contact your H.C. Wainwright representative or Lily Khaykina at [email protected].
Where can I access the conference presentation from BIO-key?
The conference presentation will be available on demand on the conference website starting September 11th, 2026, at 7:00 a.m. ET.
What is BIO-key International's area of expertise?
BIO-key International specializes in identity and access management and biometric authentication technologies.
How many users does BIO-key's solution secure?
BIO-key's technology secures access for over forty million users worldwide.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$BKYI Hedge Fund Activity
We have seen 0 institutional investors add shares of $BKYI stock to their portfolio, and 16 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITIGROUP INC removed 50,349 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $227,073
- GEODE CAPITAL MANAGEMENT, LLC removed 29,543 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $133,238
- JANE STREET GROUP, LLC removed 25,317 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $13,420
- FLOW TRADERS U.S. LLC removed 11,273 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $5,975
- CITADEL ADVISORS LLC removed 3,164 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,677
- VIRTU FINANCIAL LLC removed 2,071 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $9,340
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 1,719 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $7,752
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
HOLMDEL, N.J., Sept. 01, 2026 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management and biometric authentication technologies, announced that its CEO Michael DePasquale will be available for virtual meetings at H.C. Wainwright’s 28th Annual Global Investment Conference Tuesday, September 15 th and Thursday, September 17 th . Contact your H.C. Wainwright representative or Lily Khaykina at [email protected] to schedule a meeting.
Conference Presentation Available on Demand
BIO-key’s conference presentation will be available on demand to registered attendees via
the conference website
beginning on Friday, September 11
th
at 7:00 a.m. ET and throughout the conference on the Technology, Media & Telecommunications, Growth Track (Track 2).
H.C. Wainwright & Co. is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services across multiple sectors and regions. H.C. Wainwright also provides research and sales and trading services to institutional investors. The 28 th Annual Global Investment Conference will feature leading companies across various growth segments.
About BIO-key International, Inc.
(
www.BIO-key.com
)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
| Engage with BIO-key | |
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR |
| StockTwits: | BIO_keyIR |
Investor Contacts
William Jones, David Collins
Catalyst IR
[email protected]
or 212-924-9800
